Alkaline phosphatase and hyperphosphatasemia in vitamin D trial in healthy infants and toddlers.

Freja PontánHelena Henrietta Hauta-AlusSaara ValkamaJenni Rosendahl Maria Enlund-Cerullo Sture Andersson Outimaija Mäkitie Elisa Holmlund-Suila

Published in: The Journal of clinical endocrinology and metabolism (2023)

Approximately 5% of infants had hyperphosphatasemia at 12 months, but <1% at 24 months. ALP concentrations and hyperphosphatasemia associated with sex, anthropometry, and bone mineralization. Infections did not contribute to hyperphosphatasemia.

Keyphrases

study protocol
bone mineral density
randomized controlled trial
soft tissue
phase iii
bone loss
bone regeneration
postmenopausal women